piperacillin and tazobactam for injection powder for solution
sterimax inc - piperacillin (piperacillin sodium); tazobactam (tazobactam sodium) - powder for solution - 36g; 4.5g - piperacillin (piperacillin sodium) 36g; tazobactam (tazobactam sodium) 4.5g - extended-spectrum penicillins
piperacillin and tazobactam for injection powder for solution
fresenius kabi canada ltd - piperacillin (piperacillin sodium); tazobactam (tazobactam sodium) - powder for solution - 12g; 1.5g - piperacillin (piperacillin sodium) 12g; tazobactam (tazobactam sodium) 1.5g - extended-spectrum penicillins
piperacillin and tazobactam for injection powder for solution
fresenius kabi canada ltd - piperacillin (piperacillin sodium); tazobactam (tazobactam sodium) - powder for solution - 36g; 4.5g - piperacillin (piperacillin sodium) 36g; tazobactam (tazobactam sodium) 4.5g - extended-spectrum penicillins
piperacillin and tazobactam injection powder for solution
agila specialties private limited - piperacillin sodium (unii: m98t69q7hp) (piperacillin anhydrous - unii:9i628532gx) - piperacillin anhydrous 2 g in 10 ml
piperacillin, tazobactam injection powder lyophilized for solution
x-gen pharmaceuticals, inc. - piperacillin sodium (unii: m98t69q7hp) (piperacillin anhydrous - unii:9i628532gx) - piperacillin anhydrous 3 g in 20 ml
piperacillin and tazobactam sodiumtazobactam injection powder for solution
cardinal health - piperacillin (unii: x00b0d5o0e) (piperacillin anhydrous - unii:9i628532gx) - piperacillin 3 g in 15 ml
piperacillin and tazobactam- piperacillin sodium and tazobactam sodium injection, powder, for solution
sandoz inc - piperacillin sodium (unii: m98t69q7hp) (piperacillin anhydrous - unii:9i628532gx), tazobactam sodium (unii: uxa545abtt) (tazobactam - unii:se10g96m8w) - piperacillin and tazobactam for injection is a combination product consisting of a penicillin-class antibacterial, piperacillin, and a β-lactamase inhibitor, tazobactam, indicated for the treatment of patients with moderate to severe infections caused by susceptible isolates of the designated bacteria in the conditions listed below. appendicitis (complicated by rupture or abscess) and peritonitis caused by β-lactamase producing isolates of escherichia coli or the following members of the bacteroides fragilis group: b. fragilis , b. ovatus , b. thetaiotaomicron , or b. vulgatus . the individual members of this group were studied in fewer than 10 cases. uncomplicated and complicated skin and skin structure infections, including cellulitis, cutaneous abscesses and ischemic/diabetic foot infections caused by β-lactamase producing isolates of staphylococcus aureus . postpartum endometritis or pelvic inflammatory disease caused by β-lactamase producing isolates of escherichia coli . community-acquired pneumonia (
piperacillin and tazobactam- piperacillin sodium and tazobactam sodium injection, powder, lyophilized, for solution
mitim s.r.l. - piperacillin sodium (unii: m98t69q7hp) (piperacillin anhydrous - unii:9i628532gx), tazobactam sodium (unii: uxa545abtt) (tazobactam - unii:se10g96m8w) - piperacillin and tazobactam for injection, usp is a combination product consisting of a penicillin-class antibacterial, piperacillin, and a β-lactamase inhibitor, tazobactam, indicated for the treatment of patients with moderate to severe infections caused by susceptible isolates of the designated bacteria in the conditions listed below. appendicitis (complicated by rupture or abscess) and peritonitis caused by β-lactamase producing isolates of escherichia coli or the following members of the bacteroides fragilis group: b. fragilis , b. ovatus , b. thetaiotaomicron , or b. vulgatus . the individual members of this group were studied in fewer than 10 cases. uncomplicated and complicated skin and skin structure infections, including cellulitis, cutaneous abscesses and ischemic/diabetic foot infections caused by β-lactamase producing isolates of staphylococcus aureus . postpartum endometritis or pelvic inflammatory disease caused by β-lactamase producing isolates of escherichia coli . community-acquired pneumo
piperacillin, tazobactam injection, powder, lyophilized, for solution
x-gen pharmaceuticals, inc. - piperacillin sodium (unii: m98t69q7hp) (piperacillin anhydrous - unii:9i628532gx), tazobactam sodium (unii: uxa545abtt) (tazobactam - unii:se10g96m8w) - piperacillin and tazobactam for injection is a combination product consisting of a penicillin-class antibacterial, piperacillin, and a β-lactamase inhibitor, tazobactam, indicated for the treatment of patients with moderate to severe infections caused by susceptible isolates of the designated bacteria in the conditions listed below. appendicitis (complicated by rupture or abscess) and peritonitis caused by β-lactamase producing isolates of escherichia coli or the following members of the bacteroides fragilis group: b. fragilis , b. ovatus , b. thetaiotaomicron , or b. vulgatus . the individual members of this group were studied in fewer than 10 cases. uncomplicated and complicated skin and skin structure infections, including cellulitis, cutaneous abscesses and ischemic/diabetic foot infections caused by β-lactamase producing isolates of staphylococcus aureus . postpartum endometritis or pelvic inflammatory disease caused by β-lactamase producing isolates of escherichia coli . community-acquired pneumonia (
piperacillin, tazobactam injection, powder, lyophilized, for solution
x-gen pharmaceuticals, inc. - piperacillin sodium (unii: m98t69q7hp) (piperacillin anhydrous - unii:9i628532gx), tazobactam sodium (unii: uxa545abtt) (tazobactam - unii:se10g96m8w) - piperacillin and tazobactam for injection is a combination product consisting of a penicillin-class antibacterial, piperacillin, and a β-lactamase inhibitor, tazobactam, indicated for the treatment of patients with moderate to severe infections caused by susceptible isolates of the designated bacteria in the conditions listed below. appendicitis (complicated by rupture or abscess) and peritonitis caused by β-lactamase producing isolates of escherichia coli or the following members of the bacteroides fragilis group: b. fragilis , b. ovatus , b. thetaiotaomicron , or b. vulgatus . the individual members of this group were studied in fewer than 10 cases. uncomplicated and complicated skin and skin structure infections, including cellulitis, cutaneous abscesses and ischemic/diabetic foot infections caused by β-lactamase producing isolates of staphylococcus aureus . postpartum endometritis or pelvic inflammatory disease caused by β-lactamase producing isolates of escherichia coli . community-acquired pneumonia (